In-Vitro Safety Testing
Regulatory Services
Select Service Type
In-vitro Safety
-
In-vitro cytotoxicity (Balb/c 3T3) neutral red uptake assayDRF/CB/IVS-01
In-vitro cytotoxicity (Balb/c 3T3) neutral red uptake assay to evaluate Acute mammalian toxicity (oral) using Murine fibroblast (Balb/C 3T3), measuring Neutral red uptake.
Cell Model
Murine fibroblast (Balb/C 3T3)End Point
Neutral red uptakeReference Drugs
Sodium Lauryl SulphateRelevance
Acute mammalian toxicity (oral)
-
In-vitro CFU-GM assayDRF/CB/IVS-02
In-vitro CFU-GM assay to evaluate Hematotoxicity using Murine Bone marrow cells, measuring Colony Counting.
Cell Model
Murine Bone marrow cellsEnd Point
Colony CountingReference Drugs
PaclitaxelRelevance
Hematotoxicity
-
In vitro skin irritation assay (Reconstructed Human Epidermis)DRF/CB/IVS-03
In-vitro skin irritation assay (Reconstructed Human Epidermis) to evaluate dermal safety using reconstructed Human Epidermis, measuring viability by MTT.
Cell Model
Reconstructed Human EpidermisEnd Point
Viability by MTTReference Drugs
SDSRelevance
Dermal safety
-
In-vitro eye irritation assay (HET-CAM)DRF/CB/IVS-04
In vitro eye irritation assay (HET-CAM) to evaluate ocular safety using Chorioallantoic membrane of fertilized chicken egg, measuring Irritation score.
Cell Model
Chorioallantoic membrane of fertilized chicken eggEnd Point
Irritation scoreReference Drugs
SDSRelevance
Ocular safety
Non-GLP Safety
-
Determination MTD to select safe dose for efficacy studiesPCY/MTD-01
Determination MTD to select safe dose for efficacy studies in Swiss Albino Mice to study relevant biological pathways.
Animal Model
Swiss Albino MiceEnd Point
% Body Weight Change, Mortality, Hematology & BiochemistryReference Drugs
-